Close Menu
    What's Hot

    The Structural Decision for Setting Up a Life Settlement Vehicle in Ireland

    September 23, 2026
    Litigation

    Litigation Update: U.S. Bank National Association v. Pacific Life Insurance Company

    September 23, 2026

    Q&A: Beat Hess, Managing Partner, AA-Partners

    September 23, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Pacific Life Re Executes First Asset-Intensive Reinsurance Transaction in Hong Kong

      September 9, 2026

      Bermuda Life & Annuity Sidecar Market Quadruples as Alternative Asset Manager/Life Insurance Convergence Continues

      September 9, 2026

      New Report Suggests Global Life/Annuity Reinsurers Poised for Steady Growth

      August 27, 2026

      Pacific Life Re Completes Third Asset-Intensive Flow Reinsurance Transaction in Japan

      August 19, 2026

      US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

      August 13, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      Q&A: Dr Christoph Schmitt, Director, Insurance, Fitch Ratings

      May 28, 2026

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Pension Risk Transfer Transactions Up, Aggregate Premium Down in Second Quarter

      September 21, 2026
      Just Group

      Engineering Council Pension Scheme Completes Bulk Purchase Annuity Buy-Out With Just Group

      September 16, 2026

      Special Melted Products Pension Scheme Completes Bulk Purchase Annuity Transaction With Canada Life

      September 15, 2026

      M&G Completes Bulk Purchase Annuity Transaction in Financial Services Industry

      September 14, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026

      The Structural Decision for Setting Up a Life Settlement Vehicle in Ireland

      September 23, 2026
      Litigation

      Litigation Update: U.S. Bank National Association v. Pacific Life Insurance Company

      September 23, 2026

      Q&A: Beat Hess, Managing Partner, AA-Partners

      September 23, 2026

      Awareness Raising is More Than Just a One-Month Campaign for Life Settlement Market

      September 9, 2026

      The Structural Decision for Setting Up a Life Settlement Vehicle in Ireland

      September 23, 2026
      Litigation

      Litigation Update: U.S. Bank National Association v. Pacific Life Insurance Company

      September 23, 2026

      Q&A: Beat Hess, Managing Partner, AA-Partners

      September 23, 2026

      US Pension Risk Transfer Transactions Up, Aggregate Premium Down in Second Quarter

      September 21, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 9, September 2026

      September 9, 2026

      Editor’s Letter – Volume 2, Issue 8, August 2026

      August 12, 2026

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Q&A: Beat Hess, Managing Partner, AA-Partners

    Longevity and Mortality Risk Transfer September 23, 2026By Greg Winterton
    Share
    Twitter LinkedIn Email

    Internal rate of return (IRR) is a common measure of performance in life settlement investing, but Beat Hess, Managing Partner of AA-Partners, argues that Distributed to Paid-In (DPI) is a better judge of realised performance. Greg Winterton caught up with Beat to learn more about why he favours this approach in this month’s Q&A. 

    GW: Beat, DPI is a well-used metric in a range of private market asset classes/categories. Why do you prefer it to IRR, which arguably has been used for longer, particularly in life settlements?  

    BH: The target IRR of a fund is used in the private markets as well as in the life settlement market for pricing assets at the point of purchase. But, at the same time, the IRR is a marketing instrument, because that IRR is used in communications with investors.  

    But once a life settlement portfolio is running, investors want to know how it is performing, both generally and compared to their target IRR. One way to describe ongoing performance is the IRR – by combining the realised cashflows so far, together with a valuation of the policies not yet matured. The issue with this approach is that the valuation is based on assumptions, so the IRR of a current investment or fund can paint a rosier picture, even if the investment is actually not performing. 

    A second way, and one we prefer, is to describe the ongoing performance using DPI. Investors want investable cash back; the return of capital is what matters, and this is measured by the DPI. The DPI does not depend on assumptions, making it difficult to ‘skew’. It is purely about cashflows which makes it easy to understand – and tangible.  

    The DPI is a great metric to report the performance of a life settlement investment, and the necessary information is readily available via standard bookkeeping tools.  

    GW: DPI proponents argue that it bypasses valuations and prevents skewed assumptions. What is a hypothetical scenario where a life settlement fund shows a strong IRR, but its actual DPI paints a drastically different, riskier picture? 

    BH: A life settlement portfolio generates two types of cashflows: cash-in from collected death benefits and cash-out from premium payments and cost. Thus, the balance of the two cashflows is decisive for the success of the investment, which is what the DPI measures.  

    Imagine a life settlement portfolio where the cash collected from mortalities does not, or does not significantly, exceed the cost (the payments of premiums to keep the other policies in-force). The DPI of such a fund would paint a dire picture, since the investment would not be going well at that point in time. And rightfully so, since the ultimate risk of this investment is a partial (or even total, in an extreme situation) loss for the investors if the cash-in does not continue to exceed substantially the cash-out. 

    The same portfolio can show, however, an attractive IRR since the value of the remaining portfolio, which depends on a range of assumptions, is considered in the IRR calculation, together with the to-date realised cashflows.  

     Again, we think this is why the DPI is so useful. Valuation assumptions can affect the reported value of the portfolio and lead to a rosy IRR, but they cannot create cash distributions. DPI cuts through that distinction by showing how much capital has actually been returned to investors. 

    GW: Because life settlements require ongoing premium payments before death benefits are collected, early-stage DPIs can look low. How should investors fairly evaluate a fund’s DPI during those initial hold-to-maturity years? 

    BH: Yes, this is correct. The DPI of a young portfolio can indeed look ‘unattractive’ while the portfolio is actually on track to deliver acceptable returns. But in this case, looking at the actual-to-expected (A/E) – the metric used by institutional investors and actuaries to measure the accuracy and quality of medical underwriting and life expectancy (LE) estimates – would tell the true story. A portfolio can be considered to be on track, even though the DPI does not appear to be strong, if the A/E confirms that policy maturities in the early years are happening as or close to when they are expected to. 

    GW: What specific standards or metrics do you think should be required of life settlement asset managers to report to investors to reduce the risk of an incomplete performance picture? 

    BH: At a minimum, we think that investors should receive a clear quarterly picture of the actual cash flows of the portfolio: cash-in from collected death benefits and cash-out for premium payments and other costs. This, on top of the actual-to-expected ratio (which should be included anyway in all documentation) would help to provide investors with the information they need to more effectively judge the performance of a portfolio at that particular time.  

    GW: What do you think is needed in order for life settlement asset managers to adopt DPI as a preferred performance measure, and how should the industry go about achieving this? 

    BH: The cash-in and cash-out information of every fund is available via standard bookkeeping tools and processes, so data availability is not the issue.  

    And I don’t think the industry needs another complex reporting framework. For us, DPI is straightforward; it’s based on information every manager already has, and it’s well-known. Thus, we think that other managers confident in the cash performance of their portfolios have little reason not to provide it. 

    Beat Hess is Managing Partner at AA-Partners  

    2026 - September Life Settlements Volume 2 Issue 10 – October 2026
    Share. Twitter LinkedIn Email

    Related Posts

    The Structural Decision for Setting Up a Life Settlement Vehicle in Ireland

    September 23, 2026By Greg Winterton
    Litigation

    Litigation Update: U.S. Bank National Association v. Pacific Life Insurance Company

    September 23, 2026By Greg Winterton

    US Pension Risk Transfer Transactions Up, Aggregate Premium Down in Second Quarter

    September 21, 2026By LMI Newsdesk
    Just Group

    Engineering Council Pension Scheme Completes Bulk Purchase Annuity Buy-Out With Just Group

    September 16, 2026By LMI Newsdesk
    Latest Issue

    Awareness Raising is More Than Just a One-Month Campaign for Life Settlement Market

    September 9, 2026

    Slowing US PRT Market Sees Insurers Jostling for Business as Buy-Ins Surge

    September 9, 2026

    Bermuda Life & Annuity Sidecar Market Quadruples as Alternative Asset Manager/Life Insurance Convergence Continues

    September 9, 2026

    Insurers Sweeten Bulk Purchase Annuity Offers as Buy-Out Timetables – and Costs – Look Set To Increase

    August 26, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.